Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives
Abstract Nowadays, a potent challenge in cancer treatment is considered the lack of efficacious strategy, which has not been able to significantly reduce mortality. Chemoimmunotherapy (CIT) as a promising approach in both for the first-line and relapsed therapy demonstrated particular benefit from t...
Main Authors: | Rafieh Bagherifar, Seyed Hossein Kiaie, Zahra Hatami, Armin Ahmadi, Abdolvahid Sadeghnejad, Behzad Baradaran, Reza Jafari, Yousef Javadzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-00861-0 |
Similar Items
-
Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?
by: Muneyuki Masuda, et al.
Published: (2021-09-01) -
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
by: Weiwei Mu, et al.
Published: (2020-07-01) -
Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
by: Qijun Lv, et al.
Published: (2020-09-01) -
Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
by: Jun Gu, et al.
Published: (2022-08-01) -
Induction chemoimmunotherapy may improve outcomes of chemoradiotherapy in patients with unresectable stage III NSCLC
by: Song Guan, et al.
Published: (2023-11-01)